U.S. flag

An official website of the United States government

NM_000218.3(KCNQ1):c.521G>A (p.Arg174His) AND Cardiovascular phenotype

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Nov 16, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002336182.3

Allele description [Variation Report for NM_000218.3(KCNQ1):c.521G>A (p.Arg174His)]

NM_000218.3(KCNQ1):c.521G>A (p.Arg174His)

Gene:
KCNQ1:potassium voltage-gated channel subfamily Q member 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11p15.5
Genomic location:
Preferred name:
NM_000218.3(KCNQ1):c.521G>A (p.Arg174His)
HGVS:
  • NC_000011.10:g.2570671G>A
  • NG_008935.1:g.130681G>A
  • NM_000218.3:c.521G>AMANE SELECT
  • NM_001406836.1:c.521G>A
  • NM_001406837.1:c.251G>A
  • NM_181798.2:c.140G>A
  • NP_000209.2:p.Arg174His
  • NP_000209.2:p.Arg174His
  • NP_001393765.1:p.Arg174His
  • NP_001393766.1:p.Arg84His
  • NP_861463.1:p.Arg47His
  • NP_861463.1:p.Arg47His
  • LRG_287t1:c.521G>A
  • LRG_287t2:c.140G>A
  • LRG_287:g.130681G>A
  • LRG_287p1:p.Arg174His
  • LRG_287p2:p.Arg47His
  • NC_000011.9:g.2591901G>A
  • NM_000218.2:c.521G>A
  • NM_181798.1:c.140G>A
  • NR_040711.2:n.414G>A
  • P51787:p.Arg174His
Protein change:
R174H
Links:
UniProtKB: P51787#VAR_008939; dbSNP: rs199472697
NCBI 1000 Genomes Browser:
rs199472697
Molecular consequence:
  • NM_000218.3:c.521G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406836.1:c.521G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406837.1:c.251G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_181798.2:c.140G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Cardiovascular phenotype
Identifiers:
MedGen: CN230736

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002642027Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Likely pathogenic
(Nov 16, 2023)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

[Congenital long QT syndrome. The value of genetics in prognostic evaluation].

Denjoy I, Lupoglazoff JM, Donger C, Berthet M, Richard P, Neyroud N, Villain E, Lucet V, Coumel P, Guicheney P.

Arch Mal Coeur Vaiss. 1999 May;92(5):557-63. French.

PubMed [citation]
PMID:
10367071

A new approach to long QT syndrome mutation detection by Sequenom MassARRAY system.

Allegue C, Gil R, Sanchez-Diz P, Torres M, Quintela I, Carracedo A, BriĆ³n M.

Electrophoresis. 2010 May;31(10):1648-55. doi: 10.1002/elps.201000022.

PubMed [citation]
PMID:
20486126
See all PubMed Citations (6)

Details of each submission

From Ambry Genetics, SCV002642027.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

The p.R174H variant (also known as c.521G>A), located in coding exon 3 of the KCNQ1 gene, results from a G to A substitution at nucleotide position 521. The arginine at codon 174 is replaced by histidine, an amino acid with highly similar properties. This variant has been described in association with long QT syndrome (LQTS) (Splawski I et al. Circulation. 2000;102(10):1178-85; Lupoglazoff JM et al. J. Am. Coll. Cardiol. 2004;43(5):826-30; Shimizu W et al. J. Am. Coll. Cardiol. 2004;44(1):117-25; Kapplinger JD et al. Heart Rhythm. 2009;6(9):1297-303). Functional analysis suggests this alteration causes a dominant negative trafficking defect (Vanoye CG et al. Circ Genom Precis Med, 2018 11;11:e002345; Huang H et al. Sci Adv. 2018;4:eaar2631). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024